Evidence map›Paper›PMID 39195559›Full record

ArticleMetabolites2024

Metabolite Predictors of Breast and Colorectal Cancer Risk in the Women's Health Initiative.

Sandi L Navarro, Brian D Williamson, Ying Huang, G A Nagana Gowda, Daniel Raftery, Lesley F Tinker, Cheng Zheng, Shirley A A Beresford, Hayley Purcell, Danijel Djukovic and 6 more

Abstract read
In one paragraph

Article in Metabolites, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. NMR-based metabolomics: Where are we now and where are we going?Progress in nuclear magnetic resonance spectroscopy
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sandi L NavarroCancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.ORCID 0000-0002-4260-2486
Brian D WilliamsonBiostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, WA 98101, USA.ORCID 0000-0002-7024-548X
Ying HuangVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.ORCID 0000-0002-9655-7502
G A Nagana GowdaDepartment of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0002-0544-7464
Daniel RafteryDepartment of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0003-2467-8118
Lesley F TinkerCancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Cheng ZhengDepartment of Biostatistics, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0002-6562-870X
Shirley A A BeresfordCancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Hayley PurcellDepartment of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98195, USA.
Danijel DjukovicDepartment of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98195, USA.
Haiwei GuCenter for Metabolic and Vascular Biology, College of Health Solutions, Arizona State University, Phoenix, AZ 85004, USA.
Howard D StricklerDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Fred K TabungDepartment of Internal Medicine, Division of Medical Oncology, College of Medicine and Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA.ORCID 0000-0001-8193-7150
Ross L PrenticeCancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Marian L NeuhouserCancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Johanna W LampeCancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
WOMEN'S HEALTH INITIATIVE - CLINICAL COORDINATING CENTER: TASK AREA B - LONG LIFE STUDY VISIT 2 LIMITED HOME VISIT75N92021D00001 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ANDERSON, GARNET L. · 2021 to 2025
$52.0M
PILOT STUDY--CLINICAL NUTRITION RESEARCHP30DK035816 · NIDDK · UNIVERSITY OF WASHINGTON · PI Ellen A Schur · 1986 to 2026
$30.4M
Nutrition and Physical Activity Assessment Study (NPAAS)R01CA119171 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Marian L Neuhouser · 2006 to 2026
$14.3M
WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC): TASK AREA A AND A275N92021D00002 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI WACTAWSKI-WENDE, JEAN · 2021 to 2025
$6.9M
WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC) - TO EXERCISE OPTION PERIOD ONE (1) AND REVISE CONTRACT ARTICLES.75N92021D00004 · NHLBI · STANFORD UNIVERSITY · PI STEFANICK, MARCIA · 2021 to 2025
$6.5M
WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC) - TO EXERCISE OPTION PERIOD ONE (1) AND REVISE CONTRACT ARTICLES.75N92021D00003 · NHLBI · OHIO STATE UNIVERSITY · PI JACKSON, REBECCA · 2021 to 2025
$5.0M
WOMEN'S HEALTH INITIATIVE (WHI) REGIONAL CENTER (RC) - TO EXERCISE OPTION PERIOD ONE (1) AND REVISE CONTRACT ARTICLES.75N92021D00005 · NHLBI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI VITOLINS, MARA · 2021 to 2025
$4.2M
Accelerating biomarker development through novel statistical methods for analyzing phase III/IV studiesR01CA277133 · NCI · FRED HUTCHINSON CANCER CENTER · PI Ying Huang · 2023 to 2026
$1.6M
Multiplexed UPLC-MS/MS System for Advanced Target MetabolomicsS10OD021562 · OD · UNIVERSITY OF WASHINGTON · PI RAFTERY, DANIEL · 2016 to 2016
$596k
NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA119171NCI NIH HHS R01 CA277133NHLBI NIH HHS 75N92021D00001NHLBI NIH HHS 75N92021D00002NHLBI, NIH, USDHHS 75N92021D00001 75N92021D00002 75N92021D00003 75N92021D00004 75N92021D00005NIDDK NIH HHS P30 DK035816NIH HHS S10 OD021562ODCDC CDC HHS S10 OD021562WHI NIH HHS 75N92021D00003WHI NIH HHS 75N92021D00004WHI NIH HHS 75N92021D00005
6 · The paper itself

Abstract

Metabolomics has been used extensively to capture the exposome. We investigated whether prospectively measured metabolites provided predictive power beyond well-established risk factors among 758 women with adjudicated cancers [

Indexed as

breast cancercolorectal cancerdietary biomarkersmetabolite predictorsmetabolomics

Identifiers

PMID39195559
PMCPMC11356420

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.